Abstract:PurposeTo determine the effectiveness of prophylactic antibiotics when placing or exchanging tunneled dialysis catheters in the chest.Materials and MethodsFresenius Vascular Care collects data from outpatient interventional centers, as part of a Q.A. and M.O.C. project. Data collection began in 2010 at 26 centers, and continues to date at 35 centers. Physicians at each center administer antibiotics based on their interpretation of best practice, with substantial variability in the administration of prophylactic antibiotics. At the time of each intervention collected data included the presence of preexisting infection, the use of antibiotic, antibiotic type, and route of administration. A follow-up phone call was made to each patient's dialysis center, one week after intervention to determine if the patient developed an infection. Data recorded in the patient's chart, was also submitted to a HIPPA compliant central database. WIRB provided a letter of exemption for data review. A statistical analysis was performed of data from 1/1/2010 through 6/30/2013. Analysis includes only tunneled chest wall catheters in patients without pre-existing infection. Data from 2010 and 2011 for catheter exchange was presented at last year's SIR meeting.ResultsNew catheter placement:3065 total patients. Data incomplete 934 patients. No antibiotics 819 patients with 5 infections. Antibiotic given 1312 patients with 3 infections. Odds ratio 2.68 p-value 0.27Catheter Exchange: 8504 total patients. Data incomplete 2488 patients. No antibiotics 2235 patients with 24 infections. Oral antibiotic 1522 patients with 7 infections. Odds ratio 2.35 p-value 0.041.IV antibiotic 2259 patients with 5 infections. Odds ratio 4.89 p-value 0.0004.There was a substantial decrease in the rate of infection in the non-antibiotic group from 1 in 42 during 2010 to 1 in 154 for the remaining 2.5 years; thus, 2010 data drove significance.ConclusionThere was no definite benefit demonstrated for the use of prophylactic antibiotics with new catheter placement. Oral and IV antibiotics significantly reduced the rate of infection following catheter exchange, but the effect is substantially stronger with IV antibiotics. PurposeTo determine the effectiveness of prophylactic antibiotics when placing or exchanging tunneled dialysis catheters in the chest. To determine the effectiveness of prophylactic antibiotics when placing or exchanging tunneled dialysis catheters in the chest. Materials and MethodsFresenius Vascular Care collects data from outpatient interventional centers, as part of a Q.A. and M.O.C. project. Data collection began in 2010 at 26 centers, and continues to date at 35 centers. Physicians at each center administer antibiotics based on their interpretation of best practice, with substantial variability in the administration of prophylactic antibiotics. At the time of each intervention collected data included the presence of preexisting infection, the use of antibiotic, antibiotic type, and route of administration. A follow-up phone call was made to each patient's dialysis center, one week after intervention to determine if the patient developed an infection. Data recorded in the patient's chart, was also submitted to a HIPPA compliant central database. WIRB provided a letter of exemption for data review. A statistical analysis was performed of data from 1/1/2010 through 6/30/2013. Analysis includes only tunneled chest wall catheters in patients without pre-existing infection. Data from 2010 and 2011 for catheter exchange was presented at last year's SIR meeting. Fresenius Vascular Care collects data from outpatient interventional centers, as part of a Q.A. and M.O.C. project. Data collection began in 2010 at 26 centers, and continues to date at 35 centers. Physicians at each center administer antibiotics based on their interpretation of best practice, with substantial variability in the administration of prophylactic antibiotics. At the time of each intervention collected data included the presence of preexisting infection, the use of antibiotic, antibiotic type, and route of administration. A follow-up phone call was made to each patient's dialysis center, one week after intervention to determine if the patient developed an infection. Data recorded in the patient's chart, was also submitted to a HIPPA compliant central database. WIRB provided a letter of exemption for data review. A statistical analysis was performed of data from 1/1/2010 through 6/30/2013. Analysis includes only tunneled chest wall catheters in patients without pre-existing infection. Data from 2010 and 2011 for catheter exchange was presented at last year's SIR meeting. ResultsNew catheter placement:3065 total patients. Data incomplete 934 patients. No antibiotics 819 patients with 5 infections. Antibiotic given 1312 patients with 3 infections. Odds ratio 2.68 p-value 0.27Catheter Exchange: 8504 total patients. Data incomplete 2488 patients. No antibiotics 2235 patients with 24 infections. Oral antibiotic 1522 patients with 7 infections. Odds ratio 2.35 p-value 0.041.IV antibiotic 2259 patients with 5 infections. Odds ratio 4.89 p-value 0.0004.There was a substantial decrease in the rate of infection in the non-antibiotic group from 1 in 42 during 2010 to 1 in 154 for the remaining 2.5 years; thus, 2010 data drove significance. New catheter placement: 3065 total patients. Data incomplete 934 patients. No antibiotics 819 patients with 5 infections. Antibiotic given 1312 patients with 3 infections. Odds ratio 2.68 p-value 0.27 Catheter Exchange: 8504 total patients. Data incomplete 2488 patients. No antibiotics 2235 patients with 24 infections. Oral antibiotic 1522 patients with 7 infections. Odds ratio 2.35 p-value 0.041. IV antibiotic 2259 patients with 5 infections. Odds ratio 4.89 p-value 0.0004. There was a substantial decrease in the rate of infection in the non-antibiotic group from 1 in 42 during 2010 to 1 in 154 for the remaining 2.5 years; thus, 2010 data drove significance. ConclusionThere was no definite benefit demonstrated for the use of prophylactic antibiotics with new catheter placement. Oral and IV antibiotics significantly reduced the rate of infection following catheter exchange, but the effect is substantially stronger with IV antibiotics. There was no definite benefit demonstrated for the use of prophylactic antibiotics with new catheter placement. Oral and IV antibiotics significantly reduced the rate of infection following catheter exchange, but the effect is substantially stronger with IV antibiotics.

A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis

Evaluation of Target Attainment for Tobramycin in Children and Adults with Cystic Fibrosis

Effects of CFTR modulators on pharmacokinetics of tobramycin during acute pulmonary exacerbations in the pediatric cystic fibrosis population

Necessity of Tobramycin trough Levels in Once Daily Iv-Treatment in Patients with Cystic Fibrosis

A Pharmacokinetic Analysis of Tobramycin in Patients Less than Five Years of Age with Cystic Fibrosis: Assessment of Target Attainment with Extended-Interval Dosing through Simulation

Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis

Comparison of the Areas Under the Curve of Vancomycin Continuous vs. Intermittent Infusion in Critically Ill Pediatrics: A Randomized Clinical Trial

Changes in Pulmonary Function and Controlled Ventilation-High Resolution CT of Chest After Antibiotic Therapy in Infants and Young Children with Cystic Fibrosis

Evaluation of Antimicrobial Susceptibility Testing Methods for Burkholderia cenocepacia and Burkholderia multivorans Isolates from Cystic Fibrosis Patients

Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients

Complications of indwelling catheters in cystic fibrosis: a 10-year review

Adverse Events from Fluoroscopic versus Portable Placement of PICCs and CVCs in Pediatric Patients

Comparison of outcomes from tunnelled femorally inserted central catheters and peripherally inserted central catheters: a propensity score-matched cohort study

Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis

Detectable Concentrations With Inhaled Tobramycin in Critically Ill Infants and Children Following Implementation of Standardized Protocol

Prophylactic Antibiotics and Tunneled Dialysis Catheter Interventions in the Chest

Ability of device to collect bacteria from cough aerosols generated by adults with cystic fibrosis

Comparison of complication types in patients receiving vesicant intravenous antimicrobials or vasopressors via midlines and peripherally inserted central catheters

Drug monitoring during ciprofloxacin prophylaxis of allogeneic stem cell transplant patients: associations with bacterial infections through a monocentric observational prospective study

Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Cystic Fibrosis

Evaluation of serum VIP and aCGRP during pulmonary exacerbation in cystic fibrosis: A longitudinal pilot study of patients undergoing antibiotic therapy